Inhibition of adenylate cyclase activity of human thyroid membranes by gangliosides.
Gangliosides inhibit basal, thyrotropin-induced and fluoride-induced adenylate cyclase activity of human thyroid membranes in physiological conditions. In contrast neutral glycolipids, phospholipids and neuraminic acid containing oligosaccharides show no effect. The efficacy of inhibition is more dependent upon the position of the sialic acid residues than upon their absolute number. In general gangliosides with disialyl groups are more inhibitory than those with single sialyl moieties. The inhibitory effects of the individual gangliosides on the two modes of stimulation are parallel. This parallelism suggests that the inhibitory effect is located at the postreceptor level and that the gangliosides interact directly with the adenylate cyclase system. A possible role of thyroid membrane gangliosides as suppressive cofactors of adenylate cyclase is discussed in relation to recent findings of stimulating anti-ganglioside antibodies in Graves' disease.
D000067956:Adenylyl Cyclase Inhibitors; D005732:Gangliosides / Q000494:pharmacology*; D006801:Humans; D008566:Membranes / Q000201:enzymology; D012969:Sodium Fluoride / Q000494:pharmacology; D013961:Thyroid Gland / Q000187:drug effects / Q000201:enzymology*; D013972:Thyrotropin / Q000494:pharmacology
D000067956:Adenylyl Cyclase Inhibitors; D005732:Gangliosides; D012969:Sodium Fluoride; D013972:Thyrotropin